Biolinq

Biolinq is a healthcare technology company based in San Diego, focused on wearable biosensors that enhance metabolic health. The company develops precision multi-analyte sensors that operate just beneath the skin's surface, providing real-time health insights. Their flagship product is a wearable patch featuring microsensors that measure glucose levels and other biomarkers, designed for painless, continuous monitoring. The biosensor platform utilizes proprietary materials science and semiconductor manufacturing techniques to create compact, high-precision sensors. Biolinq primarily targets individuals with Type 2 diabetes, offering a user-friendly alternative to traditional continuous glucose monitors. The company is advancing its technology through significant funding and clinical trials, with plans for FDA submission in late 2024. Led by CEO Richard Yang, Biolinq collaborates with various investors and experts to drive innovation in wearable health technology.

Medical Devices San Diego, United States ~114 employees Private · Series C

Work at Biolinq in HR or recruiting? Claim this page

Employees
114
+3.6% in the 3 months to Sep 2026
Revenue / employee
$219K
Revenue ~$25M
Total funding
$279M
Last round Series C, Apr 2025
12-month attrition
8.7%
Tech: 6.4%
H1B sponsor
NA

Hiring now

Biolinq FAQ

How many employees does Biolinq have?

Biolinq has about 114 employees, up 3.6% over the 3 months to Sep 2026.

What is Biolinq's revenue per employee?

Biolinq makes about $219K in revenue per employee, based on $25M annual revenue and 114 employees.

How much funding has Biolinq raised?

Biolinq has raised $278.9M in total funding; its latest round was Series C in Apr 2025.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.